Search research articles
Contact Us
Filters
Showing results (71-80 of 102) with videos related to
Page
of 11
Sort By:
Journal of Endocrinological Investigation
|
February 7, 2023
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions
E Macerola, A M Poma, P Vignali, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2001
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults
R Elisei, C Romei, T Vorontsova, et al.
Clinical Endocrinology
|
January 5, 2007
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients
T Rago, G Di Coscio, F Basolo, et al.
Journal of Endocrinological Investigation
|
July 17, 2010
Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice
E Papini, R Negro, A Pinchera, et al.
Journal of Endocrinological Investigation
|
August 19, 2016
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland
R Ciampi, C Romei, L Pieruzzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2004
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure
G Orgiana, G Pinna, A Camedda, et al.
Journal of Endocrinological Investigation
|
October 28, 2004
Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer
S Lisi, F Menconi, M A Altea, et al.
Journal of Endocrinological Investigation
|
May 5, 2020
Proteinuria is a late-onset adverse event in patients treated with cabozantinib
V Cappagli, D Moriconi, A G Bonadio, et al.
Journal of Endocrinological Investigation
|
April 25, 2018
mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study
S Mazzeo, R Cervelli, R Elisei, et al.
Endocrine-Related Cancer
|
June 17, 2009
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role
E Fiore, T Rago, M A Provenzale, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 102) with videos related to
Sort By:
Page
of 11
Journal of Endocrinological Investigation
|
February 7, 2023
MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions
E Macerola, A M Poma, P Vignali, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 10, 2001
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults
R Elisei, C Romei, T Vorontsova, et al.
Clinical Endocrinology
|
January 5, 2007
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients
T Rago, G Di Coscio, F Basolo, et al.
Journal of Endocrinological Investigation
|
July 17, 2010
Thyroid nodule and differentiated thyroid cancer management in pregnancy. An Italian Association of Clinical Endocrinologists (AME) and Italian Thyroid Association (AIT) Joint Statement for Clinical Practice
E Papini, R Negro, A Pinchera, et al.
Journal of Endocrinological Investigation
|
August 19, 2016
Classical point mutations of RET, BRAF and RAS oncogenes are not shared in papillary and medullary thyroid cancer occurring simultaneously in the same gland
R Ciampi, C Romei, L Pieruzzi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 9, 2004
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure
G Orgiana, G Pinna, A Camedda, et al.
Journal of Endocrinological Investigation
|
October 28, 2004
Failure to use measurement of megalin secretory components complexed with serum thyroglobulin as a tool to identify metastases after surgery in papillary thyroid cancer
S Lisi, F Menconi, M A Altea, et al.
Journal of Endocrinological Investigation
|
May 5, 2020
Proteinuria is a late-onset adverse event in patients treated with cabozantinib
V Cappagli, D Moriconi, A G Bonadio, et al.
Journal of Endocrinological Investigation
|
April 25, 2018
mRECIST criteria to assess recurrent thyroid carcinoma treatment response after radiofrequency ablation: a prospective study
S Mazzeo, R Cervelli, R Elisei, et al.
Endocrine-Related Cancer
|
June 17, 2009
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role
E Fiore, T Rago, M A Provenzale, et al.
Page
of 11